The Patent Finder
US

Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders

US 10,947,544 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Feb 14, 2025 · Medium confidence

Filed Feb 28, 2019 as application 16/289,374 · Granted Mar 16, 2021
Base term, 20 years from filing
Today
20 years from filing
Term ended Feb 14, 2025
2005 2026
Clock starts
Feb 14, 2005
Term ended
Feb 14, 2025
Granted
Mar 16, 2021
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,538,211, US 7,579,456, US 7,803,931, US 8,236,773, US 8,436,164, US 9,617,546, to Feb 14, 2025. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 14, 2005, when application 11/058,134, the earliest non-provisional in its chain, was filed (this one was filed Feb 28, 2019); a parent in its chain could not be resolved (the next row)Feb 14, 2025High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,538,211, US 7,579,456, US 7,803,931, US 8,236,773, US 8,436,164, US 9,617,546)resolves to Feb 14, 2025, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderFeb 14, 2025Medium confidence

This family

US 7,803,931Term ended
Feb 2025
Feb 2025
US 7,538,211Term ended
Feb 2025
Feb 2025
US 7,579,456Term ended
no later than Feb 2025
no later than Feb 2025
US 8,236,773Term ended
Nov 2026
Nov 2026
US 8,436,164Term ended
Feb 2025
Feb 2025
US 9,617,546Term ended
no later than Feb 2025
no later than Feb 2025
US 10,947,544this patent
Feb 2025
Feb 2025
US 11,913,000Term ended
Apr 2025
Apr 2025
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 5, 2022
Reel 61088, frame 48
Iveric Bio, Inc.Hercules Capital, Inc.Security Interest
Jun 29, 2023
Reel 64114, frame 743
Benedict, Claude; Epstein, David; Wilson, Charles; McCauley, Dilara; Kurz, Jeffrey; Kurz, Markus; McCauley, Thomas Greene; Rottman, JamesArchemix Corp.Assignment of Assignor's Interest
Jun 29, 2023
Reel 64115, frame 418
Archemix Corp.Archemix LLCMerger
Jul 17, 2023
Reel 64286, frame 472
Hercules Capital, Inc.Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio, Inc.Release of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio Gene Therapy LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Orion Ophthalmology LLCRelease of Security Interest
Sep 7, 2023
Reel 64834, frame 160
Archemix LLCIveric Bio., Inc.Assignment of Assignor's Interest
Jun 26, 2024
Reel 67851, frame 643
Iveric Bio, Inc.Astellas US LLCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited